Pharmacological Studies in Hospitalized COVID-19 Patients in Belgium: We Could Do Better
Belgium has actively participated in clinical research on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) since the beginning of the pandemic to help identify effective and safe treatments for COVID-19. The objective of this review is to provide a picture of the clinical studies carried...
Main Authors: | Maya Hites, Jean-Louis Vincent |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/7/1427 |
Similar Items
-
Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells
by: Susanna K.P. Lau, et al.
Published: (2020-12-01) -
Immune Profiling of SARS-CoV-2; What We Know and What We Don’t Know
by: Mahshid Zohouri, et al.
Published: (2023-06-01) -
Severe Acute Respiratory Syndrome Coronavirus 2 and Respiratory Virus Sentinel Surveillance, California, USA, May 10, 2020–June 12, 2021
by: Gail L. Sondermeyer Cooksey, et al.
Published: (2022-01-01) -
Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018–2022
by: Faruque Ahmed, et al.
Published: (2023-12-01) -
Isolation of Bat Sarbecoviruses, Japan
by: Shin Murakami, et al.
Published: (2022-12-01)